Leadership & Scientific Collaboration
Paul Tausch
Co-Founder, De Facto Diagnostics, LLC
De Facto Diagnostics was founded by Paul and Kim Tausch, united by a shared passion for advancing transplantation research.
​
Paul brings more than four decades of experience in transplant diagnostics, with a career spanning One Lambda, Thermo Fisher Scientific's Transplant Diagnostics business, and CareDx.
​
His experience throughout the evolution of the field has shaped the company's vision: developing innovative technologies that address the needs of today's researchers while anticipating the challenges of tomorrow.
​
De Facto Diagnostics builds on this foundation by collaborating with experts who share a commitment to scientific innovation and advancing transplantation research.
Curt Lind
Founder, Heirloom Diagnostics, LLC
Chief Scientific Advisor, De Facto Diagnostics
Curt Lind, Founder of Heirloom Diagnostics, LLC, serves as Chief Scientific Advisor to De Facto Diagnostics.
​
Paul and Curt have collaborated for more than 25 years, building a longstanding professional relationship grounded in their shared understanding of transplant diagnostics and vision for the field's future.
​
Their combined experience and commitment to innovation form the foundation of an exclusive collaboration between the two companies, focused on developing technologies for transplantation research.
​
Together, Paul and Curt draw on decades of scientific expertise and industry experience to develop innovative technologies that expand research capabilities and create new opportunities for discovery in HLA and transplantation research.
De Facto Diagnostics and Heirloom Diagnostics share a vision for the future of transplantation research—and a commitment to helping move the field forward.